Title rated 0 out of 5 stars, based on 0 ratings(0 ratings)
Book, 2016
Current format, Book, 2016, Second edition, All copies in use.
Book, 2016
Current format, Book, 2016, Second edition, All copies in use. Offered in 0 more formats
With availability of more effective treatment regimens, many people who have lymphoma are living longer: there are more than 700,000 lymphoma survivors in the United States alone. Responding to improvements in lymphoma treatments and survival, the second edition of this book places a greater emphasis on survivorship. The book includes the latest information on lymphoma diagnosis, treatment, and incidence and describes recent updates to the WHO system of lymphoma classification and staging. Adler discusses new targeted therapies like ibrutinib and idelalisib and describes how some treatments, including radiation therapy and stem cell transplants, have been modified while others have been discontiued. She also addresses new developments, such as the use of medical marijuana and the question of whether lack of sunlight and vitamin D play a role in the development of lymphoma.
From the community